Febrile Neutropenia
📧 Sign up to get email alerts when something new happens for Febrile Neutropenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia [NA]
This is a completed clinical trial evaluating piperacillin/tazobactam for empirical therapy of febrile neutropenia. Phase information is not…
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Daptomycin Versus Placebo in Patients With Neutropenia and Fever [Phase 3]
A Phase 3 trial comparing daptomycin to placebo in patients with febrile neutropenia was terminated, and results were posted.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia [Phase 3]
Phase 3 clinical trial comparing levofloxacin with cefepime in cancer patients with fever and neutropenia; current status is unknown.
-
CLINICAL_TRIALS research · 2013-08-12Clinical Trial Update: Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia [Phase 3]
This update covers a Phase 3 trial comparing early hospital discharge with standard inpatient care for cancer patients receiving antibiotics…
-
CLINICAL_TRIALS research · 2013-07-08Clinical Trial Update: Garlic in Patients With Febrile Neutropenia [Phase 1, Phase 2]
The document outlines an early-phase clinical trial evaluating garlic in patients with febrile neutropenia associated with chemotherapy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-06-07Clinical Trial Update: Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia [NA]
This clinical trial update reports that the study evaluating short-term antibiotic treatment for unexplained fever in solid cancer patients …
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy [Phase 3]
Phase 3 completed trial comparing pegfilgrastim and filgrastim as supportive therapy in breast cancer patients receiving chemotherapy.
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients [Phase 4]
Phase 4 clinical trial update evaluating the diagnostic LightCycler SeptiFast Test MGRADE for pathogen detection in neutropenic hematology p…
-
CLINICAL_TRIALS research · 2012-09-12Clinical Trial Update: Registry of Febrile Neutropenia and Invasive Fungal Infections
This entry describes an ongoing registry tracking febrile neutropenia and invasive fungal infections in patients with hematologic diseases.
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile Neutropenia
The trial evaluated new blood culture methods to improve microbiological documentation in febrile neutropenia. The study status is completed…
-
CLINICAL_TRIALS trial_result · 2012-06-05Clinical Trial Update: Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients [Phase 4]
Phase 4 pharmacokinetic/pharmacodynamic study of doripenem in febrile neutropenic patients completed; results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2011-12-29Clinical Trial Update: Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe Infections [Phase 4]
A Phase 4 trial evaluated diagnosing septicaemia in severe infections by detecting microbial DNA in blood, involving febrile neutropenia, en…
-
CLINICAL_TRIALS trial_result · 2011-11-03Clinical Trial Update: Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options
Pfizer conducted an observational, non-interventional study in febrile neutropenia patients to evaluate antibacterial therapeutic options; t…
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: Procalcitonin Protocol to Shorten the Antibiotic Therapy in Febrile Neutropenia [NA]
Clinical trial evaluating a procalcitonin-guided protocol to shorten antibiotic therapy in febrile neutropenia. Status: completed.
-
CLINICAL_TRIALS trial_result · 2011-03-11Clinical Trial Update: Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics [Phase 4]
The Phase 4 trial evaluating Ambisome for culture-negative neutropenic fever unresponsive to antibiotics was terminated.
-
CLINICAL_TRIALS trial_result · 2010-08-04Clinical Trial Update: Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia
Clinical trial update showing results of a study comparing caspofungin and micafungin as empiric antifungal therapy for persistent fever and…
-
CLINICAL_TRIALS trial_result · 2009-12-01Clinical Trial Update: Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection [Phase 3]
Pfizer-sponsored Phase 3 trial evaluating treatment for febrile neutropenia patients suspected of Gram-positive infection has completed.
-
CLINICAL_TRIALS trial_result · 2009-05-12Clinical Trial Update: Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation
A completed clinical trial comparing meropenem alone versus meropenem plus a glycopeptide for febrile neutropenia after allogeneic stem cell…
-
CLINICAL_TRIALS trial_result · 2009-03-06Clinical Trial Update: Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients [Phase 4]
Phase 4 trial comparing teicoplanin and vancomycin as initial empirical antibiotics in febrile neutropenic patients; the study has completed…
-
FDA approval · 2008-03-20FDA Approved: CEFEPIME — Original Application (Sagent Pharmaceuticals)
FDA records the original approval of cefepime hydrochloride (cefepime) for Sagent Pharmaceuticals under an ANDA. The approval concerns a bro…